|
|
| Research article summary (published 26 Oct 2009): |
Implications of marked weight gain associated with atypical antipsychotic medications in children and adolescents.
Full Abstract
No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.
Author information
Author/s: Varley, Christopher K (CK); McClellan, Jon (J);
Journal and publication information
Publication Type: Comment; Editorial
Journal: JAMA : the journal of the American Medical Association (JAMA), published in United States. (Language: eng)
Reference: 2009-Oct; vol 302 (issue 16) : pp 1811-2
Dates: Created 2009/10/28; Completed 2009/11/02;
PMID: 19861677, status: MEDLINE (last retrieval date: 11/2/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
Comments and Corrections
CommentOn: JAMA. 2009 Oct 28;302(16):1765-73. (PMID: 19861668)
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
30 Oct 2002 - Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management.
30 Dec 2002 - Mechanistic connections between glucose/lipid disturbances and weight gain induced by antipsychotic drugs.
30 Dec 2004 - Antipsychotic medication: effects on regulation of glucose and lipids.
29 Sep 2001 - The elucidation of the mechanism of weight gain and glucose tolerance abnormalities induced by chlorpromazine.
5 Oct 2006 - Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients.
31 Dec 2006 - Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
8 May 2006 - Metabolic risk with second-generation antipsychotic treatment: a double-blind randomized 8-week trial of risperidone and olanzapine.
30 Mar 2008 - Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia.
30 Jan 2007 - Is olanzapine a brain-sparing medication?
30 Oct 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.